207
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Adherence to Anti-Retroviral Therapy (ART) and Its Determinants Among People Living with HIV/AIDS at Bonga, Kaffa, South-West Ethiopia

, ORCID Icon & ORCID Icon
Pages 543-554 | Received 18 Oct 2023, Accepted 20 Feb 2024, Published online: 04 Mar 2024

References

  • Koyra HC. Adherence to Antiretroviral Therapy among Adult Persons Living with HIV/AIDS in Southern Ethiopia. Inter J Virology and AIDS. 2018;5(1):2469–2567.
  • UNAIDS. Global HIV & AIDS statistics — fact sheet. Global HIV & AIDS statistics — fact sheet. UNAIDS; 2023.
  • Rosenberg NE, Shook-Sa BE, Liu M, et al. Adult HIV-1 incidence across 15 high-burden countries in sub-Saharan Africa from 2015 to 2019: a pooled analysis of nationally representative data. Lancet. 2023;10(3):175–185. doi:10.1016/S2352-3018(22)00328-9
  • FHAPCO. HIV/AIDS national strategic plan for Ethiopia, 2021-2025; 2020.
  • Center for Disease Control and Prevention (CDC) Ethiopia. Global HIV and TB. Ethiopia Country Profile (cdc.gov); 2021.
  • HAPCO. HIV prevention in Ethiopia National Road map. 2018.
  • Federal Ministry of Health (FMOH). HIV Prevention in Ethiopia National Road Map 2018 – 2020. Addis Ababa, Ethiopia: Federal HIV/AIDS Prevention and Control Office: Federal Ministry of Health, Ethiopia; 2018.
  • Kibret GD, Ferede A, Leshargie CT, et al. Trends and spatial distributions of HIV prevalence in Ethiopia. Infect Dis Poverty. 2019;8(1):90. doi:10.1186/s40249-019-0594-9
  • Ethiopian public health institute (EPHI). HIV related estimates and projections for Ethiopia–2017. Addis Ababa: Ethiopian public health institute; 2017.
  • Cevik M, Orkin C, Sax PE. Emergent resistance to dolutegravir among INSTI-naive patients on first-line or second-line antiretroviral therapy: a review of published cases. Open Forum Infect Dis. 2020;7(6):ofaa202. doi:10.1093/ofid/ofaa202
  • Benson C, Wang X, Dunn KJ, et al. Antiretroviral Adherence, Drug Resistance, and the Impact of Social Determinants of Health in HIV-1 Patients in the US. AIDS Behav. 2020;24(12):3562–3573. doi:10.1007/s10461-020-02937-8
  • Villiera JB, Katsabola H, Bvumbwe M, et al. Factors associated with antiretroviral therapy adherence among adolescents living with HIV in the era of isoniazid preventive therapy as part of HIV care. PLOS Glob Public Health. 2022;2(6):e0000418. doi:10.1371/journal.pgph.0000418
  • Fite RO. Association between adherence to Antiretroviral Therapy and place of residence among adult HIV infected patients in Ethiopia: a systematic review and meta-analysis. PLoS One. 2021;16(9):e0256948. doi:10.1371/journal.pone.0256948
  • Dibaba D, Kajela G, Chego M, et al. Antiretroviral Treatment Adherence Level and Associated Factors Among Adult HIV-Positive Patients on Both HIV/AIDS Care Models: comparative Study in Selected Hospitals of Western Ethiopia, 2019. HIV AIDS. 2021;13:1067–1078.
  • GebreEyesus F, Mitku D, Tarekegn T, et al. Levels of Adherence and Associated Factors Among Children on ART Over Time in Northwest, Ethiopia: evidence from a Multicenter Follow-Up Study. HIV AIDS. 2021;13:829–838. doi:10.2147/HIV.S323090;.
  • Tolossa T, Wakuma B, Mulisa D, et al. ART Adherence Among People Living with HIV Seeking Services from Public Health Facilities in Western Ethiopia. HIV/AIDS Res Palliative Care. 2021;13:1149–1158.
  • Alvi Y, Khalique N, Ahmad A, et al. World Health Organization dimensions of adherence to antiretroviral therapy: a study at antiretroviral therapy center, Aligarh. Indian J Community Med. 2019;44:118–124. doi:10.4103/ijcm.IJCM_164_18
  • Central Statistical agency (CSA). Population Statistics, Charts, Map & Location. Bonga Town, Ethiopia; 2022. Available from: https://www.citypopulation.de/en/ethiopia/admin/south.west/ET070911_bonga. Accessed February 20, 2023
  • Federal Ministry of Health (FMOH). Ethiopia. National Consolidated Guidelines for Comprehensive HIV Prevention, Care and Treatment. Addis Ababa: FMOH Ethiopia; 2018.
  • Iversen J, Qureshi SUH, Zafar M, et al. Adherence to antiretroviral therapy among HIV positive men who inject drugs in Pakistan. Int J Drug Policy. 2021;96:103281. doi:10.1016/j.drugpo.2021.103281
  • Piña C, Dange A, Rawat S, et al. Antiretroviral Treatment Uptake and Adherence Among Men Who Have Sex With Men and Transgender Women With HIV in Mumbai, India: a Cross-Sectional Study. J Assoc Nurses AIDS Care. 2018;29(2):310–316. doi:10.1016/j.jana.2017.10.001
  • McComsey GA, Lingohr-Smith M, Rogers R, Lin J, Donga P. Real-World Adherence to Antiretroviral Therapy Among HIV-1 Patients Across the United States. Adv Ther. 2021;38(9):4961–4974. doi:10.1007/s12325-021-01883-8
  • Addo MK, Aboagye RG, Tarkang EE. Factors influencing adherence to antiretroviral therapy among HIV/AIDS patients in the Ga West Municipality, Ghana. IJID Reg. 2022;3:218–225. doi:10.1016/j.ijregi.2022.04.009
  • Abadiga M, Hasen T, Mosisa G, Abdisa E. Adherence to antiretroviral therapy and associated factors among Human immunodeficiency virus positive patients accessing treatment at Nekemte referral hospital, west Ethiopia, 2019. PLoS One. 2020;15(5):e0232703. doi:10.1371/journal.pone.0232703
  • Carr A, Mackie NE, Paredes R, Ruxrungtham K. HIV drug resistance in the era of contemporary antiretroviral therapy: a clinical perspective. Antiviral Ther. 2023;28(5). doi:10.1177/13596535231201162
  • Angelo AT, Alemayehu DS. Adherence and Its Associated Factors among Adult HIV-Infected Patients on Antiretroviral Therapy in South Western Ethiopia, 2020. Patient Prefer Adherence. 2021;15:299–308. doi:10.2147/PPA.S298594
  • World Health Organizations. Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV. Geneva: World Health Organizations; 2015:978–992.
  • Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Department of Health and Human Services; 2022. Available from: https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-arv. Accessed February 20, 2023.
  • Byrd KK, Hou JG, Bush T, et al. Adherence and viral suppression among participants of the patient-centered human immunodeficiency virus (HIV) care model project: a collaboration between community-based pharmacists and HIV clinical providers. Clin Infect Dis. 2020;70:789–797. doi:10.1093/cid/ciz276
  • Desta AA, Kidane KM, Woldegebriel AG, et al. Level of Adherence and Associated Factors Among HIV-Infected Patients on Antiretroviral Therapy in Northern Ethiopia: retrospective Analysis. Patient Prefer Adherence. 2020;14:1585–1594. doi:10.2147/PPA.S268395
  • Mohd Salleh NA, Richardson L, Kerr T, et al. A Longitudinal Analysis of Daily Pill Burden and Likelihood of Optimal Adherence to Antiretroviral Therapy Among People Living With HIV Who Use Drugs. J Addict Med. 2018;12(4):308–314. doi:10.1097/ADM.0000000000000403
  • Fiseha T, Ebrahim H, Ebrahim E, Gebreweld A. CD4+ cell count recovery after initiation of antiretroviral therapy in HIV-infected Ethiopian adults. PLoS One. 2022;17(3):e0265740. doi:10.1371/journal.pone.0265740
  • Mantell JE, Zech JM, Masvawure TB. Implementing six multi-month dispensing of antiretroviral therapy in Ethiopia: perspectives of clients and healthcare workers. BMC Health Serv Res. 2023;23(1):563. doi:10.1186/s12913-023-09549-7